Skip to main content
OpenTrials

Clinical trial condition

Small Lymphocytic Lymphoma With 17p Deletion

Explore clinical trials studying Small Lymphocytic Lymphoma With 17p Deletion. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Small Lymphocytic Lymphoma With 17p Deletion trial results

Completed

A Multicenter Phase 2 Study of Ibrutinib in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) With 17p Deletion

NCT01744691

Conditions
Chronic Lymphocytic Leukemia With 17p Deletion, Small Lymphocytic Lymphoma With 17p Deletion
Locations
  • Phoenix, Arizona, United States
  • Duarte, California, United States
  • Greenbrae, California, United States
  • La Jolla, California, United States
View all 55 locations
View Trial Details

Related conditions